133 related articles for article (PubMed ID: 11071278)
1. Cellular effects of leishmanial tubulin inhibitors on L. donovani.
Havens CG; Bryant N; Asher L; Lamoreaux L; Perfetto S; Brendle JJ; Werbovetz KA
Mol Biochem Parasitol; 2000 Oct; 110(2):223-36. PubMed ID: 11071278
[TBL] [Abstract][Full Text] [Related]
2. Effect of the microtubule stabilising agent taxol on leishmanial protozoan parasites in vitro.
Kapoor P; Sachdeva M; Madhubala R
FEMS Microbiol Lett; 1999 Jul; 176(2):429-35. PubMed ID: 10427726
[TBL] [Abstract][Full Text] [Related]
3. Purification, characterization, and drug susceptibility of tubulin from Leishmania.
Werbovetz KA; Brendle JJ; Sackett DL
Mol Biochem Parasitol; 1999 Jan; 98(1):53-65. PubMed ID: 10029309
[TBL] [Abstract][Full Text] [Related]
4. Sinefungin and taxol effects on cell cycle and cytoskeleton of Leishmania donovani promastigotes.
Moulay L; Robert-Gero M; Brown S; Gendron MC; Tournier F
Exp Cell Res; 1996 Aug; 226(2):283-91. PubMed ID: 8806432
[TBL] [Abstract][Full Text] [Related]
5. Resistance to arsenite modulates expression of beta- and gamma-tubulin and sensitivity to paclitaxel during differentiation of Leishmania donovani.
Jayanarayan KG; Dey CS
Parasitol Res; 2002 Aug; 88(8):754-9. PubMed ID: 12122434
[TBL] [Abstract][Full Text] [Related]
6. Altered tubulin dynamics, localization and post-translational modifications in sodium arsenite resistant Leishmania donovani in response to paclitaxel, trifluralin and a combination of both and induction of apoptosis-like cell death.
Jayanarayan KG; Dey CS
Parasitology; 2005 Aug; 131(Pt 2):215-30. PubMed ID: 16145938
[TBL] [Abstract][Full Text] [Related]
7. Confocal microscopic investigation of tubulin distribution and effect of paclitaxel on posttranslationally modified tubulins in sodium arsenite resistant Leishmania donovani.
Chavan HD; Singh G; Dey CS
Exp Parasitol; 2007 Jul; 116(3):320-6. PubMed ID: 17367783
[TBL] [Abstract][Full Text] [Related]
8. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.
Mittra B; Saha A; Chowdhury AR; Pal C; Mandal S; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
Mol Med; 2000 Jun; 6(6):527-41. PubMed ID: 10972088
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanism of miltefosine-mediated death of Leishmania donovani.
Verma NK; Dey CS
Antimicrob Agents Chemother; 2004 Aug; 48(8):3010-5. PubMed ID: 15273114
[TBL] [Abstract][Full Text] [Related]
10. Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
Bhattacharya G; Salem MM; Werbovetz KA
Bioorg Med Chem Lett; 2002 Sep; 12(17):2395-8. PubMed ID: 12161141
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a taxol-resistant Leishmania donovani promastigote mutant that exhibits a multidrug-resistant phenotype.
Kapoor P; Ghosh A; Madhubala R
FEMS Microbiol Lett; 1999 Jul; 176(2):437-41. PubMed ID: 10427727
[TBL] [Abstract][Full Text] [Related]
12. Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site.
Venghateri JB; Gupta TK; Verma PJ; Kunwar A; Panda D
PLoS One; 2013; 8(10):e75182. PubMed ID: 24124473
[TBL] [Abstract][Full Text] [Related]
13. Some novel antileishmanial compounds inhibit normal cell cycle progression of Leishmania donovani promastigotes and exhibits pro-oxidative potential.
Amlabu WE; Amisigo CM; Antwi CA; Awandare GA; Gwira TM
PLoS One; 2021; 16(11):e0258996. PubMed ID: 34807936
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity and mode of action of phenolic compounds on Leishmania donovani.
Antwi CA; Amisigo CM; Adjimani JP; Gwira TM
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007206. PubMed ID: 30802252
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of 10-deacetylbaccatin III against Leishmania donovani promastigotes and intracellular amastigotes.
Georgopoulou K; Smirlis D; Bisti S; Xingi E; Skaltsounis L; Soteriadou K
Planta Med; 2007 Aug; 73(10):1081-8. PubMed ID: 17691059
[TBL] [Abstract][Full Text] [Related]
16. Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.
Jaiswal AK; Rao KB; Kushwaha P; Rawat K; Modukuri RK; Khare P; Joshi S; Mishra S; Rai A; Sashidhara KV; Dube A
Int J Antimicrob Agents; 2016 Dec; 48(6):695-702. PubMed ID: 27876275
[TBL] [Abstract][Full Text] [Related]
17. Green Synthesis of Silver and Titanium Dioxide Nanoparticles Using Euphorbia prostrata Extract Shows Shift from Apoptosis to G0/G1 Arrest followed by Necrotic Cell Death in Leishmania donovani.
Zahir AA; Chauhan IS; Bagavan A; Kamaraj C; Elango G; Shankar J; Arjaria N; Roopan SM; Rahuman AA; Singh N
Antimicrob Agents Chemother; 2015 Aug; 59(8):4782-99. PubMed ID: 26033724
[TBL] [Abstract][Full Text] [Related]
18. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.
Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM
Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646
[TBL] [Abstract][Full Text] [Related]
19. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes.
Paris C; Loiseau PM; Bories C; Bréard J
Antimicrob Agents Chemother; 2004 Mar; 48(3):852-9. PubMed ID: 14982775
[TBL] [Abstract][Full Text] [Related]
20. Antileishmanial Mechanism of Diamidines Involves Targeting Kinetoplasts.
Yang G; Choi G; No JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6828-6836. PubMed ID: 27600039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
